OBJECTIVE: The aim of this study was to investigate the treatment effects of testosterone and estrogen on the expression of proteins and genes involved in adipocyte signal transduction to lipolysis in abdominal subcutaneous adipose tissue of postmenopausal women. DESIGN: An open, randomized clinical study with parallel group comparison. SETTING:Women's health clinical research unit and a research laboratory at a university hospital. PATIENT(S): Thirty-six healthy naturally postmenopausal women. INTERVENTION(S): The participants were randomly given testosterone undecanoate (40 mg every second day) or estradiol valerate (2 mg daily) for 3 months. MAIN OUTCOME MEASURE(S): Expression of proteins and genes involved in adipocyte signal transduction to lipolysis in abdominal subcutaneous adipose tissue, determined by quantitative real-time polymerase chain reaction and Western blot, respectively, and related to plasma glycerol before or during a euglycemic hyperinsulinemic clamp. RESULT(S): Testosterone treatment decreased the expression of hormone-sensitive lipase and increased the expression of phosphodiesterase-3B, whereas no effect of estrogen was observed. Testosterone-induced changes in hormone-sensitive lipase expression correlated positively with corresponding changes in basal or clamp-induced plasma glycerol concentrations. CONCLUSION(S): Treatment with testosterone in postmenopausal women down-regulates hormone-sensitive lipase and up-regulates phosphodiesterase-3B expressions in abdominal subcutaneous adipose tissue in relation to changes in vivo of lipolytic activity, which may promote the accumulation of fat.
RCT Entities:
OBJECTIVE: The aim of this study was to investigate the treatment effects of testosterone and estrogen on the expression of proteins and genes involved in adipocyte signal transduction to lipolysis in abdominal subcutaneous adipose tissue of postmenopausal women. DESIGN: An open, randomized clinical study with parallel group comparison. SETTING:Women's health clinical research unit and a research laboratory at a university hospital. PATIENT(S): Thirty-six healthy naturally postmenopausal women. INTERVENTION(S): The participants were randomly given testosterone undecanoate (40 mg every second day) or estradiol valerate (2 mg daily) for 3 months. MAIN OUTCOME MEASURE(S): Expression of proteins and genes involved in adipocyte signal transduction to lipolysis in abdominal subcutaneous adipose tissue, determined by quantitative real-time polymerase chain reaction and Western blot, respectively, and related to plasma glycerol before or during a euglycemic hyperinsulinemic clamp. RESULT(S): Testosterone treatment decreased the expression of hormone-sensitive lipase and increased the expression of phosphodiesterase-3B, whereas no effect of estrogen was observed. Testosterone-induced changes in hormone-sensitive lipase expression correlated positively with corresponding changes in basal or clamp-induced plasma glycerol concentrations. CONCLUSION(S): Treatment with testosterone in postmenopausal women down-regulates hormone-sensitive lipase and up-regulates phosphodiesterase-3B expressions in abdominal subcutaneous adipose tissue in relation to changes in vivo of lipolytic activity, which may promote the accumulation of fat.
Authors: Jeffrey D Covington; Sudip Bajpeyi; Cedric Moro; Yourka D Tchoukalova; Philip J Ebenezer; David H Burk; Eric Ravussin; Leanne M Redman Journal: Eur J Endocrinol Date: 2014-10-23 Impact factor: 6.664
Authors: Oleg Varlamov; Ashley E White; Julie M Carroll; Cynthia L Bethea; Arubala Reddy; Ov Slayden; Robert W O'Rourke; Charles T Roberts Journal: Endocrinology Date: 2012-04-30 Impact factor: 4.736
Authors: Gregorio Chazenbalk; Prapti Singh; Dana Irge; Amy Shah; David H Abbott; Daniel A Dumesic Journal: Steroids Date: 2013-05-23 Impact factor: 2.668
Authors: Paola Gonzalo-Encabo; David Valadés; Natalio García-Honduvilla; Ana de Cos Blanco; Christine M Friedenreich; Alberto Pérez-López Journal: Eur J Appl Physiol Date: 2020-04-07 Impact factor: 3.078
Authors: Mahmoud Mustafa Ali Abulmeaty; Ali Madi Almajwal; Mohamed Farouk ElSadek; Mohamed Y Berika; Suhail Razak Journal: Int J Endocrinol Date: 2019-11-28 Impact factor: 3.257